NanoCellect and Novogene partner to deliver single cell solutions to China
San Diego, Calif., January 6, 2020 — NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced a distribution and partnership agreement with China-based Novogene to distribute NanoCellect’s WOLF® Cell Sorter, N1 Single-Cell Dispenser, consumables and software in China. In addition, Novogene will be adding the WOLF platform to advance their leading-edge genomic services and solutions business.
NanoCellect’s microfluidic solutions allow researchers to analyze and separate biological samples one cell at a time, enabling researchers to isolate cells or populations of interest from the rest of the sample more gently than conventional technology.
“As we expand our distribution of our products globally, Novogene was an obvious choice to partner with in China. Their leading global position providing single cell DNA sequencing and other single cell services, combined with their ability to distribute, service and support researchers in China make Novogene an excellent partner for NanoCellect,” said Chris Neary, CEO Of NanoCellect Biomedical, Inc. “As we continue to expand our international distribution channels, we look forward to partnering with Novogene to bring gentle single-cell sorting solutions to their customers and helping to advance research at the cellular level.”
“NanoCellect’s microfluidic cell sorting technology is very innovative, and we’re delighted to be adding their product offerings’ growing list of technology solutions for our customer base,” said Ruiqiang Li, Ph.D., Founder and CEO of Novogene.
About NanoCellect Biomedical, Inc. NanoCellect is a life science tools company that develops and manufactures innovative solutions for cell analysis and sorting based on microfluidic technology. NanoCellect’s WOLF® Cell Sorter and N1 single-cell plate dispenser provide gentle sorting to maintain cell viability. . The N1 96-well dispenser (also capable of 384-well plating) can receive anywhere from 1 to 100 cells. The WOLF® platform is used in a growing list of application areas including antibody discovery, cell line development, genomic sample preparation, CRISPR genomic editing and plant, and animal genomics. Founded in 2009, NanoCellect is headquartered in San Diego, CA. For more information, please visit https://nanocellect.com.
About Novogene Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise, and the highest capacity of advanced sequencing in the world. Novogene utilizes scientific excellence, a commitment to customer service and unsurpassed data quality to help our clients realize their research goals. The company has become a world-leader in NGS services, with 2,600 employees and multiple locations across the globe. Novogene’s depth of experience has resulted in the ownership of 27 NGS-related patents, as well as the publishing of over 4,920 customer research papers, often in well-respected publications such as Nature and Science. For more information, please visit https://en.novogene.com.